PLX8394

目录号:S7965 批次号:S796503

打印

化学数据

化学结构式 别名 N/A 储存条件
(自收到货起)
3年 -20°C 粉状
化学式

C25H21F3N6O3S

分子量 542.53 CAS号 1393466-87-9
Solubility (25°C)* 体外 DMSO 100 mg/mL (184.32 mM)
Water Insoluble
Ethanol Insoluble
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

制备储备液

生物活性

产品描述 PLX8394是一种具有口服活性的BRAF小分子抑制剂,对BRAF(V600E)、WT BRAF和CRAF的IC50分别为3.8 nM、14 nM和23 nM。它具有潜在的抗肿瘤活性。
靶点
BRAF(V600E) [2]
(Cell-free assay)
BRAF [2]
(Cell-free assay)
CRAF [2]
(Cell-free assay)
3.8 nM 14 nM 23 nM
体外研究

PLX8394不诱导RAF/MEK/ERK的反常激活。它能阻止单体BRAFV600和二聚BRAFnon-V600 protein突变引起的信号转导[1]

推荐的实验操作(此推荐来自于公开的文献所以Selleck并不保证其有效性)

细胞实验 细胞系 结肠癌细胞
浓度 1 μM
处理时间 6 h
方法

用DMSO、1 μM vemurafenib或1 μM PLX8394处理细胞6小时。

PLX8394在文献中得到引用

SB202190 Predicts BRAF-Activating Mutations in Primary Colorectal Cancer Organoids via Erk1-2 Modulation [ Cells, 2023, 12(4)664] PubMed: 36831331
Design and Synthesis of Novel 2-Acetamido, 6-Carboxamide Substituted Benzothiazoles as Potential BRAFV600E Inhibitors - In vitro Evaluation of their Antiproliferative Activity [ ChemMedChem, 2023, e202300322.] PubMed: 37792577
Classical RAS proteins are not essential for paradoxical ERK activation induced by RAF inhibitors [ Proc Natl Acad Sci U S A, 2022, 119(5)e2113491119] PubMed: 35091470
Increased IRF9-STAT2 signaling leads to adaptive resistance toward targeted therapy in melanoma by restraining GSDME-dependent pyroptosis [ J Invest Dermatol, 2022, S0022-202X(22)00096-3] PubMed: 35148998
Preclinical Characterization of a Next-Generation Brain Permeable, Paradox Breaker BRAF Inhibitor [ Clin Cancer Res, 2021, 10.1158/1078-0432.CCR-21-2761] PubMed: 34782366
Preclinical characterization of a next generation brain permeable, paradox breaker BRAF inhibitor [ Clin Cancer Res, 2021, clincanres.2761.2021] PubMed: 34782366
The stability of R-spine defines RAF inhibitor resistance: A comprehensive analysis of oncogenic BRAF mutants with in-frame insertion of αC-β4 loop [ Sci Adv, 2021, 7(24)eabg0390] PubMed: 34108213
Loss of FBXW7-mediated degradation of BRAF elicits resistance to BET inhibitors in adult T cell leukemia cells [ Mol Cancer, 2020, 19(1):139] PubMed: 32907612
Identification and characterization of a BRAF fusion oncoprotein with retained autoinhibitory domains. [ Oncogene, 2019, 10.1038/s41388-019-1021-] PubMed: 31558800
SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma [ Int J Cancer, 2018, 143(12):3131-3142] PubMed: 29905375

特定的存储和包装每个产品的信息在产品说明书上都有注明。大多数Selleck产品,在推荐的条件下存储可稳定保存两年。产品有时建议的储存温度不同,大多数建议储存在-20°C,抑制剂属于化学试剂,可在常温下运输储存两周左右。即使如此,我们保证产品的出货量将保持产品质量的条件下,一般都会放入冰袋。望阁下收到产品后,请按照产品数据表建议适当存储。

如果需要长期保存,请于零下二十度低温保存。禁止用于人体及治疗!

退换货政策

Selleck提供宽松的退换货承诺,努力为您营造最优的购物体验。每个订单Selleck只提供一次退换货服务,为了确保您的权益,请您仔细阅读以下内容:

1. 请在返还样品之前事先与我们取得联系,以确保产品是直接向我们或者当地代理商购买的;

2. 自收到货物起七天内,如因运输过程有问题或其他任何问题,您可以提出退换货要求;自收到货物起365天内,如因产品质量有问题,您可以提出退换货要求。

3. 请使用我们的快递账号进行退换货,您无需为此承担任何费用。

4. 如您已收到由Selleck开具的发票,则办理退货或订单金额发生变更的换货时,请将发票随商品一同返还给Selleck。请您妥善保管发票,如发票丢失,将无法办理退换货手续。

5. 对于合理的退换货要求,我们会在5个工作日内处理完成您的款项退还和新换货物的运输等,请耐心等待。